Dashboard
Weak Long Term Fundamental Strength with a -20.45% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 9.70% signifying low profitability per unit of shareholders funds
Flat results in Sep 25
With ROE of 4.9, it has a Very Expensive valuation with a 1.4 Price to Book Value
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 751 Cr (Micro Cap)
30.00
40
0.00%
-0.23
4.86%
1.48
Total Returns (Price + Dividend) 
Latest dividend: 4 per share ex-dividend date: Aug-22-2022
Risk Adjusted Returns v/s 
Returns Beta
News

Chemcon Speciality Chemicals: Analytical Perspective Shift Amidst Mixed Financial and Technical Signals
Recent revisions in the evaluation of Chemcon Speciality Chemicals reflect a nuanced shift in market assessment, influenced by changes across quality metrics, valuation considerations, financial trends, and technical indicators. This article examines the underlying data shaping this updated analytical perspective on the specialty chemicals company.
Read More
Chemcon Speciality Chemicals Faces Shift in Technical Momentum Amid Market Volatility
Chemcon Speciality Chemicals, a key player in the specialty chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of market forces and investor sentiment. Recent evaluation adjustments highlight a transition in price dynamics and technical indicators, signalling a cautious outlook for the stock amid broader market fluctuations.
Read More
Chemcon Speciality Chemicals: Analytical Review Highlights Key Evaluation Shifts
Recent assessment changes for Chemcon Speciality Chemicals reveal notable shifts across multiple evaluation parameters, reflecting evolving market and financial dynamics. This article examines the company's quality metrics, valuation, financial trends, and technical indicators to provide a comprehensive understanding of its current standing within the specialty chemicals sector.
Read More Announcements 
Corporate Actions 
No Upcoming Board Meetings
Chemcon Speciality Chemicals Ltd has declared 40% dividend, ex-date: 22 Aug 22
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 5 FIIs (0.27%)
Kamalkumar Rajendra Aggarwal (27.81%)
None
22.95%
Quarterly Results Snapshot (Standalone) - Sep'25 - QoQ
QoQ Growth in quarter ended Sep 2025 is 0.36% vs -2.50% in Jun 2025
QoQ Growth in quarter ended Sep 2025 is -10.02% vs 61.77% in Jun 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 9.28% vs -36.50% in Sep 2024
Growth in half year ended Sep 2025 is 3.68% vs -1.27% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'24
YoY Growth in nine months ended Dec 2024 is -26.50% vs -7.28% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 25.91% vs -63.51% in Dec 2023
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is -22.35% vs -11.82% in Mar 2024
YoY Growth in year ended Mar 2025 is 27.41% vs -65.18% in Mar 2024






